Clinical Trials on Coagulation in New Zealand
Total 391 results
-
BayerAmerican Thrombosis and Hemostasis NetworkTerminated
-
New York Presbyterian HospitalCompletedHemophilia A | Hemophilia BUnited States
-
BayerCompleted
-
Bio Products LaboratoryCompletedFactor 10 DeficiencyUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
American Thrombosis and Hemostasis NetworkBayer; Shire; CSL Behring; Bioverativ Therapeutics Inc.Completed
-
Bioverativ Therapeutics Inc.CompletedHemophilia AUnited States, Canada, Italy, Australia, Austria, Belgium, Brazil, France, Germany, Hong Kong, India, Ireland, Israel, Japan, Netherlands, New Zealand, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
OctapharmaCompletedCongenital Fibrinogen Deficiency | AfibrinogenemiaIran, Islamic Republic of, United States, Bulgaria, India, Switzerland, United Kingdom
-
Baxalta now part of ShireBaxter BioScienceCompleted
-
BayerActive, not recruitingHemophilia ACanada, Spain, United States, Belgium, Italy, Taiwan, Slovenia
-
Genentech, Inc.Approved for marketingHemophilia AUnited States
-
Newark Beth Israel Medical CenterGenentech, Inc.Not yet recruiting
-
Spark TherapeuticsChildren's Hospital of Philadelphia; University of Pittsburgh; St. James's Hospital... and other collaboratorsTerminated
-
University of MiamiShireTerminated
-
Baxalta now part of ShireCompletedHemophilia AUnited States, France, Austria, United Kingdom, Germany, Belgium, Canada, Italy, Sweden
-
CSL BehringCompletedFactor XIII DeficiencyUnited States
-
BayerTerminatedHemophilia ABelgium, Italy, Spain, United States, Canada, Switzerland, Estonia, Taiwan, France, Chile, Netherlands, United Kingdom, Austria, New Zealand, South Africa, Romania, Croatia, Israel, Germany, Poland, Australia, Denmark, Turkey, Argentina, Lithuan... and more
-
The University of Texas Health Science Center,...Baxter Healthcare Corporation; Rho, Inc.CompletedHemophilia AUnited States, Austria, Italy, Netherlands, Sweden
-
CSL BehringCompletedFactor XIII DeficiencyUnited States, Spain
-
Bioverativ, a Sanofi companySwedish Orphan BiovitrumCompletedHemophilia AUnited States, France, Italy, Spain, Netherlands, United Kingdom, Ireland, New Zealand, Poland, Australia, Germany, Brazil, Sweden, Canada
-
Weill Medical College of Cornell UniversityUniversity of Pennsylvania; CSL BehringCompletedHemophilia A | Hemophilia BUnited States, Puerto Rico
-
Baxalta now part of ShireBaxter Innovations GmbHTerminatedHemophilia APoland, United States, Bulgaria, Serbia, Canada, Russian Federation, Germany, Netherlands, Lithuania, Czechia, Austria, Spain
-
New York Presbyterian HospitalManchester University NHS Foundation TrustTerminated
-
Spark TherapeuticsCompletedHemophilia AUnited States, Australia, Canada, Israel, Thailand
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia B | HaemostasisUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerWithdrawnHemophilia ABelgium, Italy, Spain, United States, United Kingdom, Germany, France
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedEssential ThrombocythemiaUnited States, Australia, New Zealand, United Kingdom, Hong Kong, Germany, Italy
-
Rockefeller UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingGlanzmann ThrombastheniaUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
Baxalta now part of ShireCompletedHemophilia AUnited States, France, United Kingdom, Spain, Germany, Canada, Puerto Rico, Italy, Sweden, Austria
-
University Hospital, GenevaCompletedAfibrinogenemia, CongenitalFrance, Turkey, Switzerland, Netherlands, Spain, India, Poland, Canada, United States, Algeria, Egypt, Germany, Italy, Japan, Kuwait, Lebanon, Morocco, Pakistan, Serbia, Slovakia, Tunisia
-
Emory UniversityGenentech, Inc.Withdrawn
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Spain, United Kingdom, Taiwan, Malaysia, Bulgaria, Hong Kong, Korea, Republic of, Netherlands, Turkey, Ukraine
-
BloodworksErgomed; Octapharma; Mary M. Gooley Hemophilia CenterRecruiting
-
Spark Therapeutics, Inc.Recruiting
-
PfizerCompletedHemophilia BUnited States, Spain, Croatia, Serbia, Russian Federation, Canada, Hungary, Italy, Romania
-
Imago BioSciences, Inc., a subsidiary of Merck...Active, not recruitingPrimary Myelofibrosis | Thrombocythemia, EssentialUnited States, Australia, Hong Kong, Germany, Italy, New Zealand, United Kingdom
-
University Hospital, BonnSwedish Orphan BiovitrumRecruitingHaemophilia A | Synovitis | Hemophilia Arthropathy | SonographyGermany
-
Novo Nordisk A/SCompletedHaemophilia A, Haemophilia B, ObesityUnited States
-
BayerRecruitingHemophilia A | Prophylaxis of BleedingUnited States
-
Baxalta now part of ShireCompleted
-
CSL BehringCompleted
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AUnited States, France, Germany, Italy, South Africa, Spain, Turkey, Japan, United Kingdom, Costa Rica
-
Centers for Disease Control and PreventionCompletedBlood Coagulation Disorders | Blood Platelet Disorders | Menorrhagia | Hematologic Disease | Von Willebrand DiseaseUnited States
-
Baylor College of MedicineShireActive, not recruiting
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AIndia